- Home
- NAUT vs SEER Comparison
NAUT vs SEER Comparison
Compare NAUT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- SEER
- Stock Information
- Founded
- NAUT 2016
- SEER 2017
- Country
- NAUT United States
- SEER United States
- Employees
- NAUT N/A
- SEER N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- SEER Medicinal Chemicals and Botanical Products
- Sector
- NAUT Industrials
- SEER Health Care
- Exchange
- NAUT Nasdaq
- SEER Nasdaq
- Market Cap
- NAUT 95.6M
- SEER 113.8M
- IPO Year
- NAUT N/A
- SEER 2020
- Fundamental
- Price
- NAUT $0.72
- SEER $2.06
- Analyst Decision
- NAUT Strong Sell
- SEER
- Analyst Count
- NAUT 1
- SEER 0
- Target Price
- NAUT $1.75
- SEER N/A
- AVG Volume (30 Days)
- NAUT 263.6K
- SEER 139.2K
- Earning Date
- NAUT 10-28-2025
- SEER 11-05-2025
- Dividend Yield
- NAUT N/A
- SEER N/A
- EPS Growth
- NAUT N/A
- SEER N/A
- EPS
- NAUT N/A
- SEER N/A
- Revenue
- NAUT N/A
- SEER $16,288,000.00
- Revenue This Year
- NAUT N/A
- SEER $27.77
- Revenue Next Year
- NAUT N/A
- SEER $20.28
- P/E Ratio
- NAUT N/A
- SEER N/A
- Revenue Growth
- NAUT N/A
- SEER 10.52
- 52 Week Low
- NAUT $0.62
- SEER $1.62
- 52 Week High
- NAUT $3.09
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- NAUT 51.79
- SEER 48.71
- Support Level
- NAUT $0.70
- SEER $2.02
- Resistance Level
- NAUT $0.80
- SEER $2.11
- Average True Range (ATR)
- NAUT 0.05
- SEER 0.06
- MACD
- NAUT 0.01
- SEER 0.01
- Stochastic Oscillator
- NAUT 56.20
- SEER 64.29
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.